FDA withdraws bebtelovimab antibody because it is not effective against omicron BQ.1

CNBC Health and Science Read CNBC’s latest global health coverage: An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey on March 5, 2021. Mike Segar | Reuters A key monoclonal antibody used to treat people with weakened immune systems who catch Covid is no longer licensed …

FDA withdraws bebtelovimab antibody because it is not effective against omicron BQ.1 Read More »